GlassScriptPhysician profile
Armando Chapa
NPI 1881888766
$3,117.98
in general payments reported to CMS, 2019-2025
24 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $692 · 2022: $594 · 2023: $867 · 2024: $526 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,832.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $651.41 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $630.10 | 2021-2025 | |
| Lilly USA, LLC | $582.91 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Teva Pharmaceuticals USA, INC. | $179.77 | 2022-2023 | Austedo Xr, Austedo |
| Bayer Healthcare Pharmaceuticals INC. | $137.04 | 2024 | |
| Mimedx Group, INC. | $125.16 | 2025 | |
| Si-Bone, INC. | $120.28 | 2022 | |
| Novo Nordisk INC | $119.91 | 2021-2023 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $110.71 | 2025 | Voquezna |
| Abbott Laboratories | $92.79 | 2021-2024 | Proclaim, Freestyle Libre 3 |
| Amgen INC. | $88.27 | 2021-2023 | Repatha, Otezla |
| Exact Sciences Corporation | $49.66 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $40.61 | 2022 | |
| Mannkind Corporation | $28.90 | 2022 | |
| Pfizer INC. | $27.39 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.71 | 2022 | |
| Glaxosmithkline, LLC. | $17.59 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.32 | 2021 | |
| Esperion Therapeutics, INC. | $15.32 | 2021 | |
| Nevro Corp. | $14.54 | 2023 | Senza |
| Vanda Pharmaceuticals INC. | $13.89 | 2023 | Fanapt, Hetlioz |
| Sanofi-Aventis U.S. LLC | $12.61 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.27 | 2022 | |
| Amarin Pharma, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Chapa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.